Biotech · Private company
Chinook Therapeutics, Inc.
Track this companyFree. Adds Chinook Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- BION-1301Phase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- BION-1301Phase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
- CHK336Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Open-label Safety and PK Study of BION-1301 in Japanese Healthy SubjectsPHASE1 · COMPLETED · started Jul 19, 2022ClinicalTrials.gov NCT05508204 · fetched Nov 12, 2026
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CHK-336 in Healthy VolunteersPHASE1 · TERMINATED · started Apr 8, 2022ClinicalTrials.gov NCT05367661 · fetched Nov 12, 2026
- Safety and Tolerability of BION-1301 in Adults With Relapsed or Refractory Multiple Myeloma (MM)PHASE1_PHASE2 · TERMINATED · started Nov 15, 2017ClinicalTrials.gov NCT03340883 · fetched Nov 12, 2026